Charles River Laboratories (CRL)

Debt-to-capital ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	3,596,880	3,305,990	3,251,700	3,108,600	2,976,290	2,626,850	2,647,710	2,610,180	2,534,820	2,426,570	2,318,440	2,183,930	2,114,600	1,896,940	1,752,640	1,651,980	1,634,580	1,532,310	1,455,070	1,398,110
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $3,596,880K)
= 0.00

The debt-to-capital ratio of Charles River Laboratories has consistently been 0.00 over the past few years as per the data provided in the table. A debt-to-capital ratio of 0.00 indicates that the company has either no debt or a negligible amount of debt relative to its total capital structure. This signifies that Charles River Laboratories relies primarily on equity financing rather than debt to support its operations and growth. A low or zero debt-to-capital ratio can be viewed positively by investors and creditors as it implies lower financial risk and may suggest a strong financial position. However, it is important to note that while a low debt-to-capital ratio is generally favorable, excessive reliance on equity financing may also limit the company's ability to leverage debt for potential strategic investments or growth opportunities in the future.